Marks & Spencer’s customers have been left unable to make online orders for a fourth day as the retailer struggles to deal with a cyber attack that has lasted more than a week.

The blue-chip index nudged up on Monday to mark its 11th straight day in the green.

Boeing or Airbus: Which one should you choose?

The energy sector can be a great place for investors to collect a lucrative passive income stream. Many energy companies generate lots of excess cash flow, giving them the money to pay hefty dividends. Several companies in the sector also have long dividend growth streaks.

As part of today's Market Minute, Brad Smith examines some of the trading session's top stories. China's Huawei is reportedly testing a new artificial intelligence (AI) chip to rival Nvidia (NVDA), according to reporting from the Wall Street Journal. Plug Power (PLUG) stock surges after announcing a $525 million debt deal. Airbus (AIR.PA) is buying plants from Spirit Aerosystems (SPR) as Boeing (BA) is set to acquire the rest of the parts company. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Airbus (AIR) said on Monday that it agreed to acquire some of Sprit Aerosystems’s facilities for making jet parts, completing a carve-up with Boeing (BA) of the struggling supplier and taking direct control of production.

↘️ Nvidia (NVDA): The Wall Street Journal reported Huawei Technologies is gearing up to test its newest AI processor, which the Chinese company hopes could replace some higher-end Nvidia products. The U.

We recently published a list of Top 10 Stocks to Watch as Investors Brace for Recession. In this article, we are going to take a look at where Boeing Co (NYSE:BA) stands against other top stocks to watch as investors brace for recession. Despite some optimism in the market after President Donald Trump’s indication of […]

Domino's Q1 Earnings Up, Revenue Underwhelms Amid Domestic Weakness

CG Oncology, Inc. (NASDAQ:CGON) announced on Saturday that cretostimogene grenadenorepvec monotherapy data were presented at the 2025 American Urological Association Annual Meeting. The Phase 3 BOND-003 Cohort C study is in patients with high-risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette Guerin (BCG) treatment with carcinoma in situ (CIS) with or without Ta or T1 disease. The study reported 75.5% complete response (CR) at any time, with 34 confirmed CRs at 24